APA (7th ed.) Citation

B, Z., Y, M., L, C., J, Z., R, S., J, Y., . . . P, J. (2018). Loss of pleckstrin-2 reverts lethality and vascular occlusions in JAK2V617F-positive myeloproliferative neoplasms. The Journal of clinical investigation, 128(1), 125. https://doi.org/10.1172/JCI94518

Chicago Style (17th ed.) Citation

B, Zhao, et al. "Loss of Pleckstrin-2 Reverts Lethality and Vascular Occlusions in JAK2V617F-positive Myeloproliferative Neoplasms." The Journal of Clinical Investigation 128, no. 1 (2018): 125. https://doi.org/10.1172/JCI94518.

MLA (9th ed.) Citation

B, Zhao, et al. "Loss of Pleckstrin-2 Reverts Lethality and Vascular Occlusions in JAK2V617F-positive Myeloproliferative Neoplasms." The Journal of Clinical Investigation, vol. 128, no. 1, 2018, p. 125, https://doi.org/10.1172/JCI94518.